Ultragenyx Pharmaceutical Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx |
|---|---|---|---|
| FY2021 | $-338.7M | $-411.8M | $73.1M |
| FY2022 | $-380.5M | $-496.6M | $116.1M |
| FY2023 | $-475.0M | $-519.0M | $44.0M |
| FY2024 | $-414.0M | $-421.0M | $7.0M |
| FY2025 | $-466.0M | $-472.0M | $6.0M |